A new report outlines priorities for studying adults with autism, ranging from designing diagnostic tests to the most effective models of long-term care.

Swiss drugmaker Novartis plans to close its neuroscience research facility in Switzerland, but research on fragile X drugs will continue.

A new technique efficiently screens for compounds that enhance or inhibit the formation of synapses, the junctions between neurons, according to a study published 25 October in Nature Communications.

A drug that blocks a type of receptor at the junctions between neurons reverses repetitive behaviors in a mouse model of autism, according to a new study.

Some forms of autism are caused by too many proteins at the synapse, the junction between neurons, whereas other forms result from too few, according to a study published 23 November in Nature.

Supplements of omega-3 fatty acids, prime ingredients of fish oils, don’t improve symptoms in children with autism, according to a new review.

Oxytocin, the so-called ‘love hormone,’ plays a key role in monogamy in rodents, but its association with human relationships is subtle at best.

Researchers have identified a compound that shows promise as a treatment for Angelman syndrome, a developmental disorder related to autism. The unpublished results were presented Tuesday at the 2011 Society for Neuroscience annual meeting in Washington, D.C.

A small fraction of young children with autism have low levels of folate, a B vitamin, in their cerebrospinal fluid, according to unpublished research presented at the 2011 Society for Neuroscience annual meeting in Washington, D.C.

Drugs that act on the adrenaline system can alleviate autism-like symptoms in a rat model of the disorder, according to unpublished research presented Sunday in Washington, D.C.